New non-opioid pain killer get FDA approval for acute pain. Patients are taking note. Also demonstrated efficacy, just not ...

A soon-to-be landmark HSS study followed under 55 year old TKA patients for 40 years. Outcome? Almost no revisions. The ...

New Stanford and UPenn study found up to 66% of patient comorbidities missed at the initial patient admission stage. Why? How ...